VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc.

VYNE | NASDAQ
Chart Builder DCF Calculator
$28.56
$0.00 (0.00%)
Nov 2, 2026, 10:36 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-26.74M -39.83M -28.45M -23.21M -73.33M -255.57M
Depreciation & Amortization
23K 4K n/a 72K 109K 341K
Stock-Based Compensation
2.31M 3.3M 3.31M 4.3M 8.08M 18.1M
Other Working Capital
-99K -114K 214K -349K -371K -4.17M
Other Non-Cash Items
-525K -2.44M -254K -12.64M 2.47M 84.07M
Deferred Income Tax
n/a n/a n/a n/a 1.53M 56.3M
Change in Working Capital
-8.19M 5M 60K 2.28M 4.78M -40.33M
Operating Cash Flow
-33.12M -33.97M -25.34M -29.2M -56.37M -137.08M
Capital Expenditures
n/a -117K n/a n/a n/a -113K
Cash Acquisitions
n/a n/a 5M 15.67M n/a 38.64M
Purchase of Investments
-30.93M -60.52M -62.35M n/a n/a -38.64M
Sales Maturities Of Investments
68.3M 84M n/a n/a 1.03M 50.58M
Other Investing Acitivies
n/a n/a n/a n/a n/a 38.64M
Investing Cash Flow
37.37M 23.37M -57.35M 15.67M 1.03M 89.11M
Debt Repayment
n/a n/a n/a n/a -36.43M n/a
Common Stock Repurchased
n/a -141K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -67K -28K 228K 169K
Financial Cash Flow
-143K -141K 82.39M 1.65M 39.78M 61.81M
Net Cash Flow
4.1M -10.75M -301K -11.88M -15.56M 13.83M
Free Cash Flow
-33.12M -34.09M -25.34M -29.2M -56.37M -137.2M
Adj. Free Cash Flow
-35.43M -37.39M -28.65M -33.5M -64.45M -155.3M
Maintenance CapEx
n/a -108.45K n/a n/a n/a n/a
Growth CapEx
n/a -8.55K n/a n/a n/a -113K
Owner Earnings
-33.12M -34.08M -25.34M -29.2M -56.37M -137.08M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.